The role of intestinal bacteria in the transformation of sodium picosulfate - PubMed (original) (raw)
The role of intestinal bacteria in the transformation of sodium picosulfate
D H Kim et al. Jpn J Pharmacol. 1992 May.
Free article
Abstract
Sodium picosulfate, a laxative, was biotransformed to 4,4'-dihydroxydiphenyl-(2 pyridyl)-methane by intestinal flora that produced a novel sulfotransferase (not sulfatase). The biotransformation was activated by adding phenolic compounds such as phenol, acetaminophen and flavonoids. The enzyme activity related to this biotransformation was the highest in the contents of the caecum region of the intestine. The enzyme activity was 3.0 mumole/hr/g wet feces in humans and 0.75 in rats (pH 8.0). The optimal pH was 9.0.
Similar articles
- Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.
Jauch R, Hankwitz R, Beschke K, Pelzer H. Jauch R, et al. Arzneimittelforschung. 1975 Nov;25(11):1796-1800. Arzneimittelforschung. 1975. PMID: 1243088 - Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women.
Friedrich C, Richter E, Trommeshauser D, de Kruif S, van Iersel T, Mandel K, Gessner U. Friedrich C, et al. Drug Metab Pharmacokinet. 2011;26(5):458-64. doi: 10.2133/dmpk.dmpk-11-rg-007. Epub 2011 Jun 21. Drug Metab Pharmacokinet. 2011. PMID: 21697613 - Interaction between Shaoyao-Gancao-Tang and a laxative with respect to alteration of paeoniflorin metabolism by intestinal bacteria in rats.
He JX, Goto E, Akao T, Tani T. He JX, et al. Phytomedicine. 2007 Aug;14(7-8):452-9. doi: 10.1016/j.phymed.2006.09.014. Epub 2006 Nov 9. Phytomedicine. 2007. PMID: 17097282 - Transformation of flavonoids by intestinal microorganisms.
Blaut M, Schoefer L, Braune A. Blaut M, et al. Int J Vitam Nutr Res. 2003 Mar;73(2):79-87. doi: 10.1024/0300-9831.73.2.79. Int J Vitam Nutr Res. 2003. PMID: 12747214 Review. - Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?
Noergaard M, Traerup Andersen J, Jimenez-Solem E, Bring Christensen M. Noergaard M, et al. Scand J Gastroenterol. 2019 Jan;54(1):27-34. doi: 10.1080/00365521.2018.1563806. Epub 2019 Jan 31. Scand J Gastroenterol. 2019. PMID: 30700194 Review.
Cited by
- How to Determine the Role of the Microbiome in Drug Disposition.
Bisanz JE, Spanogiannopoulos P, Pieper LM, Bustion AE, Turnbaugh PJ. Bisanz JE, et al. Drug Metab Dispos. 2018 Nov;46(11):1588-1595. doi: 10.1124/dmd.118.083402. Epub 2018 Aug 15. Drug Metab Dispos. 2018. PMID: 30111623 Free PMC article. Review. - Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.
Martinelli F, Thiele I. Martinelli F, et al. Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16. Gut Microbes. 2024. PMID: 39150897 Free PMC article. Review. - Mechanism of action and toxicities of purgatives used for colonoscopy preparation.
Adamcewicz M, Bearelly D, Porat G, Friedenberg FK. Adamcewicz M, et al. Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):89-101. doi: 10.1517/17425255.2011.542411. Expert Opin Drug Metab Toxicol. 2011. PMID: 21162694 Free PMC article. Review. - The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine.
Mousa S, Sarfraz M, Mousa WK. Mousa S, et al. Metabolites. 2023 May 21;13(5):674. doi: 10.3390/metabo13050674. Metabolites. 2023. PMID: 37233715 Free PMC article. Review. - Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage.
Cai J, Auster A, Cho S, Lai Z. Cai J, et al. J Adv Res. 2023 Oct;52:171-201. doi: 10.1016/j.jare.2023.07.002. Epub 2023 Jul 5. J Adv Res. 2023. PMID: 37419381 Free PMC article.